City page
Tartu biotech and pharma directory
Tartu is Estonia's research city and the country's biotech anchor — built on the University of Tartu and the Estonian Genome Project. Anchor companies include Icosagen Group (cGMP biologics manufacturing, antibody discovery), TBD Pharmatech (API CDMO), Solis BioDyne (molecular biology reagents — qPCR enzymes used worldwide), Asper Biogene (clinical genetics and molecular diagnostics), and BioCC (drug development services). Tartu Biotechnology Park and the Tehnopol-affiliated science parks host most operators.
Where does this city read strongest?
Biotech (3), CDMO (2), and Manufacturing (2). Most visible records: Arpengen, Power Algae, and PharmaSynth.
Which standards and public evidence are already visible?
GMP (3) and ISO-13485 (2). Latest review: 21 March 2026. Review cycle: March 2026.
Why does this city matter?
This page brings visible companies and infrastructure records into one practical view of Tartu.
By category
Tartu by category
Jump into a category page filtered to this country only.
Full list
Tartu biotech and pharma directory
11 city records currently match the active filter.
Current review cycle
Arpengen
TartuEstoniaBiotech
Tartu-area biotechnology supplier developing DNA and RNA extraction kits plus related genomic-analysis and laboratory services for life-science research workflows.
- Lead
- Peyman KazemianhaddadiManagement Board Member
- Scale
- Research-product and extraction-kit manufacturing platform
Current review cycle
Power Algae
TartuEstoniaBiotech
Tartu microalgae biotechnology company building vertically integrated processes for algae valorization, CO2 utilization, and Nordic-climate bioprocess applications.
- Lead
- Liina Joller-VahterManagement Board Member
- Scale
- Applied microalgae process-development platform
Current review cycle
PharmaSynth
TartuEstoniaManufacturing
Tartu PET and SPECT precursor manufacturer operating from Tartu Science Park with GMP-aligned production, custom synthesis services, and small-scale API capability.
- Lead
- Pirkko Irene Penttila-HiltunenManagement Board Member
- Scale
- Specialty imaging-precursor and small-batch API platform
Current review cycle
BioCC
TartuEstoniaBiotech
Tartu biocompetence centre combining microbiology, clinical studies, product development, and accredited laboratory work across functional-food and health-promoting biotechnology.
- Lead
- Ene TammsaarChief Executive Officer; Member of the Board
- Scale
- Applied biotechnology and clinical-studies platform
Current review cycle
Asper Biogene
TartuEstoniaGenomics
Tartu genetic-testing laboratory offering disease-specific DNA panels, exome and genome services, and accredited diagnostic workflows from Estonia.
- Lead
- Hardi TammChief Executive Officer
- Scale
- Clinical genetic testing and sequencing services
Current review cycle
Antegenes
TartuEstoniaDiagnostics
Tartu polygenic-risk and cancer-prevention diagnostics provider combining CE-marked IVD tests, medical-genetics services, and ISO 13485 quality systems from Estonia.
- Lead
- Peeter Padrik, MD, PhDFounder and Chief Executive Officer
- Scale
- Clinical genetics and prevention-diagnostics platform
Current review cycle
State Agency of Medicines Estonia
TartuEstoniaRegulatory anchor
Tartu medicines authority coordinating authorisation, vigilance, and inspection supervision for Estonia's pharmaceutical and medical-device landscape.
- Lead
- Katrin KiiskDirector General
- Scale
- National medicines and devices authority
Current review cycle
Icosagen Group
TartuEstoniaCDMO
Tartu antibody-discovery and recombinant-protein platform now reinforced by a 1,600 m2 cGMP production facility and a broad partner network.
- Lead
- Mart UstavFounder and CEO
- Scale
- Clinical CDMO and cGMP protein manufacturing
Current review cycle
TBD Pharmatech
TartuEstoniaCDMO
Tartu API CDMO providing process chemistry, analytical development, scale-up, and GMP-oriented manufacturing support for small-molecule pharmaceutical programs.
- Lead
- Dr. Andrus TasaChairman of the Management Board
- Scale
- Clinical CDMO
Current review cycle
Estonian Genome Center
TartuEstoniaResearch
University of Tartu genomics and biobank node supporting population-scale sequencing, genotyping, and precision-medicine research built on the Estonian Biobank.
- Lead
- Prof. Elin OrgHead of Estonian Genome Centre
- Scale
- Population Scale
Current review cycle
Solis BioDyne
TartuEstoniaManufacturing
Tartu reagent manufacturer producing PCR enzymes, master mixes, and OEM-ready molecular biology inputs for diagnostics and research customers.
- Lead
- Ele ReiljanChairman of the Board and CEO
- Scale
- Global Supply
FAQ
Frequently asked questions
- Why is Tartu important for European biotech?
- Tartu hosts the University of Tartu (the country's flagship research institution), the Estonian Genome Project (one of Europe's largest population genomics initiatives), and a tight cluster of biotech operators that punches above its weight relative to city size. Icosagen runs a 1,600 m² cGMP biologics facility; Solis BioDyne supplies molecular biology reagents globally.
- What is the biggest biotech company in Tartu?
- Icosagen Group is Tartu's anchor biologics CDMO with a 1,600 m² cGMP production facility (the largest in the Baltics) — antibody discovery, recombinant protein production, stable cell line development. TBD Pharmatech operates a Tartu API CDMO. Solis BioDyne is the largest molecular tools company by international reach.
- What sectors are strongest in Tartu biotech?
- Tartu is strongest in genomics (Estonian Genome Project, Asper Biogene), molecular tools (Solis BioDyne), biologics CDMO (Icosagen), API CDMO (TBD Pharmatech), and academic-industrial translational research. The cluster is research-intensive and well-coupled to the University of Tartu.
Related briefs
Briefs that mention Tartu
Baltic CRO & Clinical Trial Landscape 2026: Lithuania, Latvia, Estonia
A practical map of the Baltic clinical research organisation landscape — Biomapas, Cureline Baltic, Inpharmatis, Asper Biogene, BioCC — and why Lithuania, Latvia, and Estonia are a credible nearshore option for EU-regulated clinical trials in 2026.
Open briefBaltic Biotech Landscape 2026: Lithuania, Latvia, Estonia
A practical map of the Baltic biotech and pharma landscape in 2026 — 74 operators across Lithuania, Latvia, and Estonia, organised by city, category, and what each actually does in the European supply chain.
Open briefEuropean Antibody & Biosimilar Therapeutics 2026: mAbs, ADCs, Biosimilars
A practical map of the European antibody + antibody-drug-conjugate + biosimilar therapeutics sector in 2026 — Genmab, ADC Therapeutics, Adcendo, Affimed, Tubulis, Heidelberg Pharma, Sandoz, Mabion, plus a Swedish + Swiss + Polish antibody innovator belt.
Open briefNext step
Read the city, then widen the view.
Use country and regional pages for wider context, and the company suggestion form for new candidate records.